Lazard Asset Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-103
| Closed | -$1K | – | 2432 |
|
|
2023
Q4 | $1K | Sell |
103
-6
| -6% | -$58 | ﹤0.01% | 2229 |
|
|
2023
Q3 | $5K | Buy |
109
+5
| +5% | +$229 | ﹤0.01% | 2178 |
|
|
2023
Q2 | $7K | Buy |
104
+4
| +4% | +$269 | ﹤0.01% | 2201 |
|
|
2023
Q1 | $8K | Buy |
100
+19
| +23% | +$1.52K | ﹤0.01% | 2148 |
|
|
2022
Q4 | $9K | Buy |
+81
| New | +$9K | ﹤0.01% | 2214 |
|